The Zika Virus RNA Qualitative Test detects the genetic material of the Zika virus in blood or other specimens using molecular amplification. This test identifies active infection during the acute phase, helping confirm Zika virus exposure and guide clinical management. It is especially useful in evaluating febrile illness, pregnancy-related risk, and travel-associated viral infections.

The West Nile Virus IgG IgM Antibodies Test measures immune response to West Nile virus, distinguishing recent from prior infection. IgM levels indicate active or recent illness, while IgG reflects past exposure or long-term immunity. This test aids in evaluating unexplained fever, flu-like symptoms, or neurological complications, supporting assessment of vector-borne viral infection and systemic health.